Cytospire TherapeuticsListed
cytospiretherapeutics.combiotech_life_sciences
Cytospire Therapeutics is a biopharmaceutical company focused on developing innovative therapies.
Portfolio
A closer look at the companies associated with this firm. Verified team members can update the portfolio after signing in.
This is the portfolio currently shown on the public firm page.
Cytospire Therapeutics is a biopharmaceutical company focused on developing innovative therapies.
Ray Therapeutics is a clinical-stage biotechnology company developing best-in-class vision restoration therapies for people with degenerative retinal diseases independent of genet…
Details are not available yet. The company remains listed.
SparingVision is a clinical-stage genomic medicines company focused on developing innovative treatments for ocular diseases, particularly inherited retinal diseases (IRDs) such as…
Araris Biotech AG is pioneering the development of a novel, proprietary antibody-drug conjugate (ADC)-linker technology that enables the attachment of payloads to 'off-the-shelf'…
Details are not available yet. The company remains listed.
ADC Therapeutics is a commercial-stage global leader and pioneer in the field of antibody drug conjugates (ADCs) advancing proprietary ADC technology to transform the treatment pa…
Developing CAR T cell therapies for patients with cancer and autoimmune diseases.
uniQure is a global leader in gene therapy, delivering innovative cures that transform lives through an AAV-based technology platform. The company focuses on treating serious unme…
Entact Bio is pioneering precision medicines that enhance the function of beneficial proteins, targeting previously undruggable pathways and addressing hard-to-treat genetic disor…
Details are not available yet. The company remains listed.
Details are not available yet. The company remains listed.
Trogenix is a pioneering biotech company dedicated to developing innovative cancer therapies through its proprietary Odysseus® platform, which targets cancer cells to deliver prec…
Actithera is a biotech company focused on developing targeted radioligand therapies for cancer, aiming to deliver personalized treatments with fewer side effects.
Details are not available yet. The company remains listed.